Wo ist der Beweis? Plädoyer für eine evidenzbasierte Medizin ...
Wo ist der Beweis? Plädoyer für eine evidenzbasierte Medizin ...
Wo ist der Beweis? Plädoyer für eine evidenzbasierte Medizin ...
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
Literatur 2353. Chalmers I. In the dark. Drug companies should be forced to publish all the resultsof clinical trials. How else can we know the truth about their products? NewScient<strong>ist</strong> 2004, 6. März, S. 19. Darin zitiert: Moore T, Deadly Medicine. NewYork: Simon and Schuster, 1995.4. Cowley AJ, Skene A, Stainer K, et al. The effect of lorcainide on arrhythmias andsurvival in patients with acute myocardial infarction: an example of publicationbias. International Journal of Cardiology 1993; 40: 161–166.5. Chalmers I. Evaluating the effects of care during pregnancy and childbirth. In:Chalmers I, Enkin M, Keirse MJNC, eds. Effective care in pregnancy and childbirth.Oxford: Oxford University Press, 1989: 3–38.6. Ulfel<strong>der</strong> H. The stilbestrol disor<strong>der</strong>s in h<strong>ist</strong>orical perspective. Cancer 1980; 45:3008–3011.7. Office of Technology Assessment. Identifying health technologies that work:searching for evidence. Washington, DC: US Government Printing Office, 1994.8. Hemminki E, McPherson K. Impact of postmenopausal hormone therapy oncardiovascular events and cancer: pooled data from clinical trials. BMJ 1997;315: 149–153.9. Anonymous. HRT: update on the risk of breast cancer and long-term safety.Current Problems in Pharmacovigilance 2003; 29: 1–3. Zitiert werden darin dieErgebnisse <strong>der</strong> randomisierten kontrollierten Studie <strong>der</strong> <strong>Wo</strong>men’s Health Initiative(JAMA 2003; 289: 3243–3253) sowie <strong>der</strong> Million <strong>Wo</strong>men Study (Lancet2003; 362: 419–427).10. Roberts H. Hormone replacement therapy comes full circle. BMJ 2007; 335:219–220.11. Williams HC. Evening primrose oil for atopic <strong>der</strong>matitis: time to say goodnight(editorial). BMJ 2003; 327: 1358–1359.12. Hoare C, Li Wan Po A, Williams H. Systematic review of treatment for atopiceczema. Health Technology Assessment 2000; 4(37): 1–191.13. Takwale A, Tan E, Agarwal S, et al. Efficacy and tolerability of borage oil inadults and children with atopic eczema: randomised, double blind, placebo controlled,parallel group trial. BMJ 2003; 327: 1385–1387.Kapitel 31. Crile G. A plea against blind fear of cancer. Life, 31. Oktober 1955, S. 128–132.2. Baum M, Houghton J. Contribution of randomised controlled trials to un<strong>der</strong>standingand management of early breast cancer. BMJ 1999; 319: 568–571.3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow up of a randomizedstudy comparing breast-conserving surgery with radical mastectomy forearly breast cancer. New England Journal of Medicine 2002; 347: 1227–1232.4. Baum M. Breast beating: a personal odyssey in the quest for an un<strong>der</strong>standing ofbreast cancer, the meaning of life and other easy questions. London: Anshan, 2010.5. Japanese Breast Cancer Society. Results of questionnaires concerning breastcancer surgery in Japan 1980–2003. Breast Cancer 2005; 12(1).6. Early Breast Cancer Trial<strong>ist</strong>s’ Collaborative Group. Effects of adjuvant tamoxifenand of cytotoxic therapy on mortality in early breast cancer. An overview© 2013 by Verlag Hans Huber, Hogrefe AG, BernDieses Dokument <strong>ist</strong> nur <strong>für</strong> den persönlichen Gebrauch bestimmt und darf in k<strong>eine</strong>r Form vervielfältigt und an Dritte weitergegeben werden.Aus: Imogen Evans, Hazel Thornton, Iain Chalmers, Paul Glasziou; <strong>Wo</strong> <strong>ist</strong> <strong>der</strong> <strong>Beweis</strong>? – <strong>Plädoyer</strong> <strong>für</strong> <strong>eine</strong> <strong>evidenzbasierte</strong> <strong>Medizin</strong>. 1. Auflage.
Change language